Atlas Trials

Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke

Clinical trial NCT01849887 · WITHDRAWN

Trial details

NCT number
NCT01849887
Sponsor
University of California, Irvine
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ischemic Stroke
Start date
2016-01-01
Primary completion
2016-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.